Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2001
08/01/2001EP1119619A2 Nlk1 -interacting proteins
08/01/2001EP1119376A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
08/01/2001EP1119371A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
08/01/2001EP1119370A1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway
08/01/2001EP1119368A2 Methods of modulating lipid metabolism and storage
08/01/2001EP1119253A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
08/01/2001EP0889959B1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
08/01/2001EP0862629B1 Epithelial membrane protein-1
08/01/2001EP0806963B1 Carcinoma treatment
08/01/2001EP0740703B1 Diagnosis and treatment of infections due to streptococci and enterococci
08/01/2001EP0667897B1 Method for specific immunoassay of human plasmatic glutathione peroxidase
08/01/2001EP0656946B1 Immunoglobulins devoid of light chains
08/01/2001EP0654532B1 Antimucoglycoprotein monoclonal antibody
08/01/2001EP0538283B2 Synthetic peptides and mixtures thereof for detecting hiv antibodies
08/01/2001CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase
08/01/2001CN1306542A Moraxella catharralis proteins
08/01/2001CN1306439A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
08/01/2001CN1306437A Vaccine
08/01/2001CN1306008A Conjugate of Lidamycin with active fragment of monoclonal antibody
08/01/2001CN1306007A Dry cell factor
08/01/2001CN1306006A BioHNTP13 molecular weight of 13 KDa and its coding sequence
08/01/2001CN1069062C Use of follicle-stimulating hormone
07/2001
07/31/2001US6269313 Method for predicting the presence of congenital and therapeutic conditions from coagulation screening assays
07/31/2001US6268486 Contacting mixture of polypeptide and impurities with specific monoclonal antibody so that binding occurs, desorbing polypeptide from antibody, and collecting polypeptide; immunoaffinity chromatography
07/31/2001US6268485 Down-regulation resistant C3 convertase
07/31/2001US6268484 HIV-vaccines
07/31/2001US6268482 Recombinant cytokine designated LERK-6
07/31/2001US6268479 Intracellular amyloid-beta peptide binding (ERAB) polypeptide
07/31/2001US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents
07/31/2001US6268221 Drug screening for compound which binds to receptor by transforming host cell with recombinant expression contruct encoding the receptor, expressing in culture, and analyzing cells to determine binding
07/31/2001US6268194 A kinase protein that phosphorylates serine 32 and serine 36; understanding the inflammatory and immune response; drug screening
07/31/2001US6268193 A non-glycosylated protein; therapeutic agent in organ transplant rejection; therapeutic agent blocking attachment of bacterial, viral, or parasitic pathogens glycoconjugate receptors; contraceptive uses
07/31/2001US6268177 An isolated polynucleotide; therapy and treatment of streptococcal infections, pneumonia, meningitis, sinusitis, conjunctivitis; screening for antibiotics
07/31/2001US6268172 A polynucleotide encoding a polypeptide for histidine kinase; screening and development of antibiotics for streptococcal diseases; otitis media, conjunctivitis, pneumonia, bacteremia pleural empyema, menegitis, sinusitis
07/31/2001US6268171 Recombinant PilC proteins, methods for producing them and their use
07/31/2001US6268138 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs
07/31/2001US6267960 Administering monoclonal antibody designated atcc no. hb-12612, hb-12616, atcc no. hb12618, or atcc no. hb-12617 which binds specifically to extracellular domain of prostate stem cell antigen (psca) to inhibit growth of prostate tumor
07/31/2001US6267959 Monoclonal antibodies having property of causing apoptosis and used as anticancer agents
07/31/2001US6267958 Lyophilized mixture of antibody which can be reconstituted with diluent to high protein concentration without loss of stability of protein; suitable for subcutaneous application
07/31/2001CA2107553C Monoclonal antibodies to stem cell factor receptors
07/31/2001CA1341277C Anti-paratopic antibody and a method of its manufacture
07/26/2001WO2001053835A2 Methods for detecting cancer of the central nervous system
07/26/2001WO2001053833A1 Mage antigenic peptides which bind hla-b35 and hla-b44
07/26/2001WO2001053530A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
07/26/2001WO2001053490A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom
07/26/2001WO2001053487A2 Human sperm specific lysozyme-like proteins
07/26/2001WO2001053486A1 Compositions and methods for the treatment of tumor
07/26/2001WO2001053469A2 Phosphatases
07/26/2001WO2001053468A2 Lipid metabolism enzymes and polynucleotides encoding them
07/26/2001WO2001053354A2 Methods for treating tumors using a fusion protein comprising il-2- polypeptides and p185-specific binding molecules
07/26/2001WO2001053353A2 Recombinant antibodies to human interkleukin-1 beta
07/26/2001WO2001053352A2 Sperm specific proteins
07/26/2001WO2001053351A2 Apoptin bindendes protein
07/26/2001WO2001053348A2 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them
07/26/2001WO2001053347A2 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
07/26/2001WO2001053344A2 Chondromodulin-i related peptide
07/26/2001WO2001053343A1 Human polynucleotides, polypeptides, and antibodies
07/26/2001WO2001053339A2 Egg specific surface proteins
07/26/2001WO2001053338A2 Cbp86, a sperm specific protein
07/26/2001WO2001053324A2 Novel haptotactic peptides
07/26/2001WO2001052889A1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
07/26/2001WO2001052884A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method
07/26/2001WO2001052879A1 Use of emap ii receptor antagonist composition for treating pulmonary hypertension
07/26/2001WO2001052664A1 Immune modulation with death receptor-induced apoptosis
07/26/2001WO2001018212A3 Mycobacterium paratuberculosis-specific antigens and their diagnostic uses
07/26/2001WO2001014415A3 Egfh2 genes and gene products
07/26/2001WO2001010902A8 Nucleoc acids and secreted polypeptides encoded thereby
07/26/2001WO2001004148A9 Donor strand complemented pilin and adhesin broad-based vaccines
07/26/2001WO2001001748A3 Peptide compounds that bind her2
07/26/2001WO2000071741A9 Dna encoding a human subunit of the 5-ht3 serotonin receptor
07/26/2001WO2000069915A3 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
07/26/2001WO2000055194A9 Tuberculosis antigens and methods of use therefor
07/26/2001WO2000045176A3 METHOD OF IDENTIFYING N-TERMINAL proBNP
07/26/2001WO2000040616A9 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41
07/26/2001WO2000017361A3 Interferon-epsilon
07/26/2001US20010009768 Polynucleotides encoding cytokine designated LERK-5
07/26/2001US20010009766 Dna encoding galanin galr3 receptors and uses thereof
07/26/2001US20010009667 Method of detecting nucleic acid encoding a retrovirus using polymerase chain reaction (pcr)
07/26/2001US20010009665 Treating a cancer patient by administering the antibodies or fragments which are cytotoxic against cancer cells but benign to noncancerous cells, in admixture with a pharmaceutical adjuvant
07/26/2001CA2479511A1 Compositions and methods for the treatment of tumor
07/26/2001CA2479498A1 Compositions and methods for the treatment of tumor
07/26/2001CA2398710A1 Egg specific surface proteins
07/26/2001CA2398695A1 Chondromodulin-i related peptide
07/26/2001CA2398256A1 Methods for detecting cancer of the central nervous system
07/26/2001CA2398083A1 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
07/26/2001CA2397946A1 Lipid metabolism enzymes
07/26/2001CA2397901A1 Cbp86, a sperm specific protein
07/26/2001CA2397896A1 Human sperm specific lysozyme-like proteins
07/26/2001CA2397838A1 Sperm specific proteins
07/26/2001CA2397833A1 Novel haptotactic peptides
07/26/2001CA2397733A1 Use of emap ii receptor antagonist composition for treating pulmonary hypertension
07/26/2001CA2397729A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method
07/26/2001CA2397617A1 Novel human nucleic acid molecules and polypeptides encoding cation channels
07/26/2001CA2397571A1 Apoptin-associating protein
07/26/2001CA2397324A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom
07/26/2001CA2396979A1 Immune modulation with death receptor-induced apoptosis
07/26/2001CA2396935A1 Phosphatases
07/26/2001CA2396212A1 Recombinant antibodies to human interleukin-1 beta
07/26/2001CA2395770A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides
07/26/2001CA2395763A1 Methods and materials relating to semaphorin-like polypeptides and polynucleotides